{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:28Z","timestamp":1759402048204,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.vaccine.2011.06.124","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T04:50:25Z","timestamp":1312260625000},"page":"7107-7113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity and safety of heptavalent conjugate vaccine against Streptococcus pneumoniae in pre-term Polish infants"],"prefix":"10.1016","volume":"29","author":[{"given":"Ewa","family":"Szynczewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta","family":"Chlebna-Sok\u00f3\u0142","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.06.124_bib0005","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998\u2014opportunities for prevention in the conjugate vaccine era","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serotypes cause the most invasive disease: implications for conjugate vaccine formulation and use. Part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(06)70520-5","article-title":"Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old","volume":"6","author":"Jefferson","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.06.124_bib0020","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.vaccine.2010.09.100","article-title":"The current status of invasive pneumococcal disease in Poland","volume":"29","author":"Skoczy\u0144ska","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0025","first-page":"1148","article-title":"Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000\u20132008","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0030","first-page":"29","article-title":"Ryzyko zaka\u017ce\u0144 pneumokokowych i skuteczno\u015b\u0107 szczepie\u0144","volume":"4","author":"Motkowski","year":"2009","journal-title":"Pediatria Po Dyplomie"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0035","first-page":"55","article-title":"Szczepienia ochronne u wcze\u015bniak\u00f3w i dzieci z ma\u0142\u0105 mas\u0105 urodzeniow\u0105","volume":"10","author":"Stryczy\u0144ska-Kazubowska","year":"2002","journal-title":"Klinika Pediatryczna"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1542\/peds.112.1.193","article-title":"Immunization of preterm and low birth weight infants, American Academy of Pediatrics Committee on Infectious Diseases","volume":"112","author":"Saari","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00148581-200709010-00003","article-title":"Active immunization of premature and low birth-weight infants","volume":"9","author":"D\u2019Angio","year":"2007","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0050","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1542\/peds.2006-2094","article-title":"Perinatal risk factors for hospitalization for pneumococcal disease in childhood: a population-based cohort study","volume":"119","author":"Mahon","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0055","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1542\/peds.109.3.498","article-title":"Seven-year follow-up of vaccine response in extremely premature infants","volume":"109","author":"Kirmani","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00006454-200203000-00003","article-title":"Efficancy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/fn.81.1.F67","article-title":"Severe apnoeas following immunization in premature infants","volume":"81","author":"Slack","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0070","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bmj.326.7394.852","article-title":"Delayed immunization and risk of pertussis in infants: unmatched case\u2013control study","volume":"326","author":"Grant","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-1759(93)90270-H","article-title":"A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies","volume":"164","author":"Konradsen","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0080","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/INF.0b013e3181d264a6","article-title":"NICHD neonatal research network. Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants","volume":"29","author":"D\u2019Angio","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/802503","article-title":"Hepatitis B response of premature infants after primary and booster immunization with a diphtheria\u2013tetanus\u2013acellular pertussis\u2013hepatitis B-inactivated poliovirus\/Haemophilus influenzae type B vaccine","volume":"802503","author":"Ome\u00f1aca","year":"2010","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria\u2013tetanus\u2013three-component acellular pertussis\u2013hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0095","first-page":"3653","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine","volume":"8","author":"Schmitt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0100","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.arcped.2003.09.039","volume":"10","author":"Reinert","year":"2003","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"K\u00e4yhty","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0110","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.vaccine.2005.11.021","article-title":"Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP. IPV\/PRP-T Hib and hepatitis B vaccines in infants 2\u20137 months of age","volume":"15","author":"Scheifele","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00006454-200009000-00009","article-title":"Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type B conjugate vaccine in United Kingdom infants","volume":"19","author":"Choo","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0120","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.vaccine.2004.09.029","article-title":"Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administrated at 3, 5 and 11 months post-natally to pre- and full-term infants","volume":"23","author":"Esposito","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vaccine.2006.07.036","article-title":"Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0130","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00214-10","article-title":"Responses to a conjugate pneumococcal vaccine in preterm infants immunized at 2, 3, and 4 months of age","volume":"17","author":"Moss","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0135","first-page":"64","article-title":"Recommendations for the production and control of pneumococcal conjugate vaccines","volume":"927","author":"World Health Organization","year":"2005","journal-title":"WHO Tech Rep Ser"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0145","first-page":"613","article-title":"Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in Taiwanese infants","volume":"103","author":"Shao","year":"2004","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0150","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.vaccine.2008.02.029","article-title":"Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar): primary dosing series in healthy Chinese infants","volume":"24","author":"Li","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0155","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1016\/j.vaccine.2007.08.022","article-title":"Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM(197) protein conjugate; Prevenar) in Korean infants: differences that are found in Asian children","volume":"7","author":"Kim","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers","volume":"25","author":"Goldblatt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0165","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.vaccine.2007.11.096","article-title":"Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTaP-IPV-HBV-Hib combination vaccine in healthy infants","volume":"26","author":"Olivier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0170","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0929-6646(09)60148-0","article-title":"Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine booster in taiwanese toddlers","volume":"105","author":"Shao","year":"2006","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0175","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/INF.0b013e3181d99345","article-title":"Immunogenicity of alternative regimens of the conjugated 7-valent pneumococcal vaccine: a randomized controlled trial","volume":"29","author":"Givon-Lavi","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0180","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children","volume":"49","author":"Recommendations of the Advisory Committee on Immunization Practices (ACIP)","year":"2000","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0185","series-title":"Vaccines","first-page":"589","article-title":"Pneumococcal conjugate vaccine","author":"Eskola","year":"2004"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0190","article-title":"Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential","author":"Greenberg","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0200","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0264-410X(03)00013-6","article-title":"Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants","volume":"21","author":"Zangwill","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10096-008-0512-8","article-title":"Invasive pneumococcal disease in children up to 5 years of age in Poland","volume":"27","author":"Grzesiowski","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0215","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/aje\/kwh191","article-title":"Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989\u20131996","volume":"160","author":"O\u2019Brien","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0220","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":"Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children","volume":"25","author":"Henckaerts","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0225","first-page":"10","article-title":"Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants","volume":"19","author":"R\u00fcckinger","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0230","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/S0264-410X(03)00389-X","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine","volume":"21","author":"Schmitt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0235","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/INF.0b013e31814614c6","article-title":"Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease","volume":"26","author":"Reinert","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0240","first-page":"65","article-title":"Kontrowersje wok\u00f3\u0142 szczepie\u0144","volume":"66","author":"Szenborn","year":"2009","journal-title":"Przegl\u0105d Lekarski"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpeds.2004.04.006","article-title":"Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events","volume":"145","author":"Pfister","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2011.06.124_bib0250","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1542\/peds.2007-2059","article-title":"Absence of an increase in cardiorespiratory events after diphtheria\u2013tetanus\u2013acellular pertussis immunization in preterm infants: a randomized, multicenter study","volume":"121","author":"Carbone","year":"2008","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:21:24Z","timestamp":1759400484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":50,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0264410X11011248"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.124","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of heptavalent conjugate vaccine against Streptococcus pneumoniae in pre-term Polish infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}